Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Increased public awareness of the role that alcohol plays in traffic injuries and deaths has led several states to enact harsher penalties for driving under its influence or for serving alcohol to an already intoxicated person who then may try to drive. Less well known or understood, however, are the possible effects on driving performance of prescription and nonprescription medications. Two pioneer meetings on this latter subject were held recently, one in Europe and the other in the United States. At the same time, the medications-and-driving question is the subject of another first step, one being taken by the National Highway Traffic Safety Administration, Washington, DC, which expects to have a provision in its forthcoming budget for an epidemiologic study. This study will gather data on drugs other than alcohol found in blood and urine specimens (JAMA [Medical News] 1985;253:3509-3517) from drivers fatally injured in traffic crashes and in a
JAMA – American Medical Association
Published: Jul 5, 1985
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.